PAA.AX
Pharmaust Ltd
Price:
0.19
AUD
Volume:
550,960
Australia | Pharmaceuticals
PAA.AX Net Margin
As of 2025-07-04, the Net Margin of Neurizon Therapeutics Ltd (PAA.AX) is -885.9%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
PAA.AX Net Margin - Historical Value
| Date | Value |
|---|---|
| 2024-06-30 | -885.9% |
| 2023-06-30 | -159.3% |
| 2022-06-30 | -37.9% |
| 2021-06-30 | -36.4% |
| 2020-06-30 | -33% |
| 2019-06-30 | -35.5% |
| 2018-06-30 | -76.5% |
| 2017-06-30 | -40.3% |
| 2016-06-30 | -142.6% |
| 2015-06-30 | -79.5% |
PAA.AX Net Margin - Peers Comparison